Skip to main content
Top
Published in: Endocrine 1/2015

01-02-2015 | Erratum

Erratum to: Low versus high radioiodine activity to ablate the thyroid after thyroidectomy for cancer: a meta-analysis of randomized controlled trials

Authors: Peizhun Du, Xuelong Jiao, Yanbing Zhou, Yu Li, Shan Kang, Dongfeng Zhang, Jizhun Zhang, Liang Lv, Rajan Patel

Published in: Endocrine | Issue 1/2015

Login to get access

Excerpt

Unfortunately, Rajan Patel was not included as one of the authors in the original publication of the article. The correct and complete order of authors and Rajan Patel’s affiliation are provided in this erratum. …
Metadata
Title
Erratum to: Low versus high radioiodine activity to ablate the thyroid after thyroidectomy for cancer: a meta-analysis of randomized controlled trials
Authors
Peizhun Du
Xuelong Jiao
Yanbing Zhou
Yu Li
Shan Kang
Dongfeng Zhang
Jizhun Zhang
Liang Lv
Rajan Patel
Publication date
01-02-2015
Publisher
Springer US
Published in
Endocrine / Issue 1/2015
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-014-0404-x

Other articles of this Issue 1/2015

Endocrine 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine